Abiraterone acetate
- Product NDC
- 72606-566
- 11-digit product format
- 726060566
- Labeler code
- 72606
- Product ID
- 72606-566_2765ab03-f2d2-4e68-a704-c1c45505b50a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abiraterone acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- CELLTRION USA, INC.
- Application
- ANDA212462
- Marketing category
- ANDA
- Marketing start
- 2020-01-07
- Marketing end
- 0000-00-00
- Substance
- ABIRATERONE ACETATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72606-566-01 | 72606056601 | 120 TABLET in 1 BOTTLE (72606-566-01) | 120 tablet | 2020-01-07 | 0000-00-00 | No | No | Current |